XKRX004080
Market cap93mUSD
Jan 09, Last price
14,450.00KRW
1D
0.35%
1Q
1.19%
Jan 2017
40.29%
Name
Shinhung Co Ltd
Chart & Performance
Profile
Shinhung Co., Ltd. manufactures and sells dental products and supplies in South Korea. Its products include implant systems; dental units, chairs, operatories, and implants; autoclaves and X-ray equipment; disposable needles; dental porcelain powder and laboratory products; dental alloys; cabinets, such as drawer cabinets, equipment cabinets, soap dispensers, sink cabinets, lateral panels, insert cabinets, and mobile cabinets; and other equipment, which include compressors and mixers. The company also offers loan services for dentists. Shinhung Co., Ltd. was founded in 1955 and is headquartered in Seoul, South Korea.
Valuation
Title KRW in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
Income | |||||||||
Revenues | 112,442,780 -4.85% | 118,176,547 -6.84% | |||||||
Cost of revenue | 87,524,449 | 94,238,794 | |||||||
Unusual Expense (Income) | |||||||||
NOPBT | 24,918,331 | 23,937,753 | |||||||
NOPBT Margin | 22.16% | 20.26% | |||||||
Operating Taxes | 2,749,317 | 1,899,440 | |||||||
Tax Rate | 11.03% | 7.93% | |||||||
NOPAT | 22,169,014 | 22,038,313 | |||||||
Net income | 9,230,505 9.06% | 8,463,561 -37.07% | |||||||
Dividends | (2,445,470) | (2,252,984) | |||||||
Dividend yield | 1.81% | 1.62% | |||||||
Proceeds from repurchase of equity | 641,726 | (857,656) | |||||||
BB yield | -0.48% | 0.62% | |||||||
Debt | |||||||||
Debt current | 8,252,751 | 6,724,942 | |||||||
Long-term debt | 1,274,498 | 1,479,420 | |||||||
Deferred revenue | |||||||||
Other long-term liabilities | 10 | ||||||||
Net debt | (7,470,838) | 2,012,925 | |||||||
Cash flow | |||||||||
Cash from operating activities | 7,642,394 | 4,418,058 | |||||||
CAPEX | (5,982,614) | (3,458,043) | |||||||
Cash from investing activities | (7,393,830) | (4,871,096) | |||||||
Cash from financing activities | (449,499) | (2,595,953) | |||||||
FCF | 13,151,157 | 18,184,477 | |||||||
Balance | |||||||||
Cash | 9,168,189 | 8,462,501 | |||||||
Long term investments | 7,829,896 | (2,271,064) | |||||||
Excess cash | 11,375,947 | 282,609 | |||||||
Stockholders' equity | 69,202,048 | 139,579,767 | |||||||
Invested Capital | 111,418,764 | 112,054,617 | |||||||
ROIC | 19.84% | 21.08% | |||||||
ROCE | 20.29% | 21.31% | |||||||
EV | |||||||||
Common stock shares outstanding | 9,417 | 9,389 | |||||||
Price | 14,340.00 -3.11% | 14,800.00 -8.36% | |||||||
Market cap | 135,041,314 -2.82% | 138,961,226 -9.27% | |||||||
EV | 127,570,477 | 140,974,151 | |||||||
EBITDA | 27,795,731 | 26,816,152 | |||||||
EV/EBITDA | 4.59 | 5.26 | |||||||
Interest | 427,678 | 407,420 | |||||||
Interest/NOPBT | 1.72% | 1.70% |